WebDisclosure WebDisclosure
Basculer en Français
9472 Companies
185369 Keywords
117719 Articles
99261 Press releases
Headlines Articles Press releases Op. Dr. Volkan Arayici Remove
  1. Home
  2. Companies
  3. Op. Dr. Volkan Arayici
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/23/2024 at 10:12, 1 year 4 months ago

    Dr. Volkan Arayıcı Leads the Way in Obesity Surgeries in Türkiye

    Health Tourism Medical Tourism Cost Efficiency Obesity Surgery Postoperative Care
  • BRIEF

    published on 07/23/2024 at 10:12, 1 year 4 months ago

    Le Dr Volkan Arayıcı ouvre la voie aux chirurgies de l'obésité en Turquie

    Tourisme De Santé Rapport Coût-efficacité Chirurgie De L'obésité Tourisme Médical Soins Postopératoires
  • PRESS RELEASE

    published on 07/23/2024 at 10:07, 1 year 4 months ago

    Dr. Volkan Arayıcı leads the way in obesity surgeries in Türkiye

    Dr. Volkan Arayıcı leads obesity surgeries in Türkiye, offering life-transforming surgeries at affordable prices. Highlighting Turkish lead in healthcare quality and affordability
    Affordability Türkiye Healthcare Quality Dr. Volkan Arayıcı Obesity Surgeries
    Logo of Op. Dr. Volkan Arayici
Accesswire
  • Published on 12/05/2025 at 02:35, 4 hours 6 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 4 hours 11 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 5 hours 41 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 7 hours 36 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 7 hours 41 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 03:30, 3 hours 10 minutes ago

    CGTN: What makes cooperation between China and France a two-way success

  • Published on 12/04/2025 at 23:50, 6 hours 50 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

  • Published on 12/04/2025 at 20:25, 10 hours 15 minutes ago

    Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

  • Published on 12/04/2025 at 20:15, 10 hours 26 minutes ago

    Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

  • Published on 12/04/2025 at 19:10, 11 hours 30 minutes ago

    SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:14, 12 hours 26 minutes ago

    Résiliation d'une convention conclue entre actionnaires

  • Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

  • Published on 12/04/2025 at 18:00, 12 hours 41 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions

  • Published on 12/04/2025 at 17:45, 12 hours 56 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy